West China Hospital: Carcinoma, Non-Small-Cell Lung trials

The registry lists 17 Carcinoma, Non-Small-Cell Lung studies with West China Hospital as lead sponsor. 13 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 4Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Perioperative Adebrelimab Plus Chemotherapy Versus Adjuvant Therapy in Patients With Resectable NSCLCNot yet recruitingNCT07895238Phase 3
• Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerRecruitingNCT07855965Phase 2
• Wireless Wearable Home Prehabilitation for Older Adults With NSCLCRecruitingNCT07809763Not applicable
• Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer ResectionNot yet recruitingNCT07797075Not applicable
• Rehabilitation With Wearable Monitors for Post-Lung Cancer SurgeryNot yet recruitingNCT07733492Not applicable
• IMP3-saRNA Vaccine in Advanced NSCLCRecruitingNCT07561723Phase 1
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer PatientsRecruitingNCT07509333Not applicable
• The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent PlatformsRecruitingNCT07310056Not applicable
• A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
• Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT07076836Not applicable
• Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLCNot yet recruitingNCT06829641
• Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung CancerNot yet recruitingNCT06779539Phase 2
• Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung CancerNot yet recruitingNCT06394427
• Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung CancerStatus unknownNCT04865705Phase 2
• Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLCCompletedNCT03712969Phase 4
• Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical ResectionTerminatedNCT03479294
• Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCStatus unknownNCT03201146Phase 1/2